Problems with interval estimates of the incremental cost-effectiveness ratio

Medical Decision Making

Volumn 19, Issue 1, 1999, Pages 9-15

  Heitjan, Daniel F ^a   Moskowitz, Alan J ^b   Whang, William ^b  

^a Columbia Univ Sch of Public Health ^*  (United States)

^b NONE

Author keywords

Bootstrap; Clinical trials; Confidence intervals; Cost effectiveness ratios; Fieller's method; Taylor series

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; MATHEMATICAL ANALYSIS; PROBABILITY; STATISTICAL ANALYSIS;

CONFIDENCE INTERVALS; COST-BENEFIT ANALYSIS; PROBABILITY;

EID: 0032894376     PISSN: 0272989X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0272989X9901900102     Document Type: Article

References (13)

1. Laska EM, Meisner M, Siegel C. Statistical inference for cost-effectiveness ratios. Health Econ. 1997;6:229-42.
2. Briggs AH, Wonderling DE, Mooney CZ. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ. 1997; 6:327-40.
3. Chaudhary MA, Stearns SC. Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial. Stat Med. 1996;15:1447-58.
4. Manning WG, Flyback DG, Weinstein MC. Reflecting uncertainty in cost-effectiveness analysis. In: Gold MR, Siegle JE, Russell LB, Weinstein MC (eds). Cost-Effectiveness in Health and Medicine. Oxford, U.K.: Oxford University Press, 1996.
5. Obenchain RL. Issues and algorithms in cost-effectiveness inference. Biopharmaceutical Report. 1997;5(2):1-7.
6. O'Brien BJ, Drummond MF, Labelle RJ, Willan A. In search of power and significance: issues in the design and analysis of stochastic cost - effectiveness studies in health care. Med Care. 1994;32:150-63.
7. Polsky D, Glick HA, Wilke R, Schulman K. Confidence intervals for cost - effectiveness ratios: a comparison of four methods. Health Econ. 1997;6:243-52.
8. Heitjan DF, Moskowitz AJ, Whang W. Bayesian estimation of cost-effectiveness ratios from clinical trials. In press, Health Econ.
9. Stinnet AA, Mullahy J. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making. 1998;18:S68-S80.
10. Scharfstein JA. Cost-Effectiveness Analysis and AIDS: Methods and Application. Doctoral thesis, Harvard University, Boston, MA, 1997.
11. Bickel PJ, Doksum KA. Mathematical Statistics. San Francisco, CA: Holden-Day, 1977.
12. Stinnet AA, Mullahy J. The negative side of cost-effectiveness analysis. JAMA. 1997;277:1931-2.
13. Finney DJ. Statistical Method in Biological Assay. 3rd ed. London, U.K.: Charles Griffin & Company, 1978.